Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice…

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, September 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 10 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 3,610 followers.

Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England https://t.co/1URxmVax2U

26 Sep 2023

Reply Repost Favourite

#Comparative #Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with #COPD in Clinical Practice in England https://t.co/tW1mKDrYuW https://t.co/Ou0AEoLV4N

22 Sep 2023

Reply Repost Favourite

21 Sep 2023

Reply Repost Favourite

UMEC/VI versus IND/GLY in patients with COPD in England | COPD @DovePress https://t.co/ZLOX40533A

17 Sep 2023

Reply Repost Favourite

Dove Medical Press

Article Metrics

Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice…

About this Attention Score

Mentioned by

Readers on